Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2006; 12(34): 5465-5472
Published online Sep 14, 2006. doi: 10.3748/wjg.v12.i34.5465
Published online Sep 14, 2006. doi: 10.3748/wjg.v12.i34.5465
Biomarkers | Tumor stage | M status | ||||
T1-2-3 (n = 28) | T4 (n = 28) | P | M0 (n = 38) | M1 (n = 18) | P | |
cagA negative (n = 32) | 54 | 63 | NS | 58 | 59 | NS |
vacA no cytotoxic strains (n = 33) | 62 | 63 | NS | 58 | 71 | NS |
TP negative (n = 42) | 93 | 65 | 0.035 | 83 | 71 | NS |
p53 negative (n = 46) | 78 | 93 | NS | 78 | 100 | 0.038 |
low MVD values (n = 27) | 56 | 46 | NS | 54 | 44 | NS |
Low VEGF-R1 expression (n = 27) | 56 | 44 | NS | 51 | 47 | NS |
High IgG levels (n = 27) | 65 | 74 | NS | 77 | 54 | NS |
Low pVEGF levels (n = 19) | 74 | 31 | 0.03 | 52 | 58 | NS |
Low sVEGF levels (n = 19) | 35 | 67 | NS | 50 | 50 | NS |
- Citation: Mangia A, Chiriatti A, Ranieri G, Abbate I, Coviello M, Simone G, Zito FA, Montemurro S, Rucci A, Leo AD, Tommasi S, Berloco P, Xu JM, Paradiso A. H pylori status and angiogenesis factors in human gastric carcinoma. World J Gastroenterol 2006; 12(34): 5465-5472
- URL: https://www.wjgnet.com/1007-9327/full/v12/i34/5465.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i34.5465